Date the warrants or rights are expired in CCYY-MM-DD format.

No definition available.

Name:	txmd_ClassOfWarrantOrRightExpirationsDateOfWarrantsOrRights
Namespace Prefix:	txmd_
Data Type:	xbrli:dateItemType
Balance Type:	na
Period Type:	duration

- Definition

Date the warrants or rights are vesting date in CCYY-MM-DD format.

+ References

No definition available.

+ Details

Name:	txmd_ClassOfWarrantOrRightVestingDateOfWarrantsOrRights
Namespace Prefix:	txmd_
Data Type:	xbrli:dateItemType
Balance Type:	na
Period Type:	duration

- Definition

The number of shares expected to vest upon receiving FDA apporval.

+ References

No definition available.

+ Details

Name:	txmd_ExpectedToVestedWarrantsUponFdaApprovalShares
Namespace Prefix:	txmd_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- References

No definition available.

+ Details

Name:	txmd_WarrantsAbstract
Namespace Prefix:	txmd_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

This item provides the weighted-average contractual remaining life of warrants.

+ References

No definition available.

+ Details

Name:	txmd_WarrantsAndRightsWeightedAverageContractualRemainingLife
Namespace Prefix:	txmd_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Weighted average price at which grantees can acquire the shares.

+ References

No definition available.

+ Details

Name:	txmd_WeightedAverageExercisePriceOfWarrants
Namespace Prefix:	txmd_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

Exercise price per share or per unit of warrants or rights outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(i)(4))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name:	us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Unrecognized cost of unvested share-based compensation awards.

+ References

+ Details

Name:	us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=66902209&loc=d3e3602-108585

+ Details

Name:	us-gaap_ShareBasedCompensation
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Period which an employee's right to exercise an award is no longer contingent on satisfaction of either a service condition, market condition or a performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).

+ References

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).

+ References

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.

+ References

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Number of non-option equity instruments exercised by participants.

+ References

+ Details

Name:	us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the expected term of a nonvested share or option award issued to other than an employee.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68057994&loc=d3e25284-112666

+ Details

Name:	us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Period an equity-based award is expected to be outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(i)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68057994&loc=d3e25284-112666

+ Details

Name:	us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1
Namespace Prefix:	us-gaap_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The estimated measure of the percentage amount by which a share price is expected to fluctuate during the expected term of a nonvested share or option award issued to other than an employee.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68057994&loc=d3e25284-112666

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(ii)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

+ Details

Name:	us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedVolatilityRate
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The risk-free interest rate assumption that is used in valuing a nonvested share or option award issued to other than an employee.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (f)(2)(iv)
-URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 50
-Section 50
-Paragraph 1
-URI http://asc.fasb.org/extlink&oid=68057994&loc=d3e25284-112666

+ Details

Name:	us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodRiskFreeInterestRate
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of shares of stock issued attributable to transactions classified as other.

+ References

No definition available.

+ Details

Name:	us-gaap_StockIssuedDuringPeriodSharesOther
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Value of shares of stock issued attributable to transactions classified as other.

+ References

No definition available.

+ Details

Name:	us-gaap_StockIssuedDuringPeriodValueOther
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(i))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name:	us-gaap_WarrantsAndRightsOutstanding
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=txmd_OutsideConsultantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=txmd_OutsideConsultant1Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=txmd_OutsideConsultant2Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=txmd_ConsultantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=txmd_Warrant1Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ClassOfWarrantOrRightAxis=txmd_Warrant2Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RangeAxis=us-gaap_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_RangeAxis=us-gaap_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_DerivativeInstrumentRiskAxis=us-gaap_WarrantMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

STOCKHOLDERS' EQUITY (Details Narrative 1) - USD ($)		1 Months Ended	3 Months Ended		9 Months Ended		35 Months Ended
STOCKHOLDERS' EQUITY (Details Narrative 1) - USD ($)	May 11, 2013	Jun. 30, 2013	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016
Warrants:
Warrants outstanding			$ 12,060,571		$ 12,060,571		$ 12,060,571
Weighted-average contractual remaining life					1 year 3 months 12 days
Share based compensation expense					$ 13,385,215	$ 4,740,906
Outside Consultant Warrants [Member]
Warrants:
Share based compensation expense			$ 137,161	$ 42,266	$ 820,751	$ 86,008
Outside Consultant Warrants [Member] \| Tranche One [Member]
Warrants:
Expiration date of warrants			Apr. 21, 2021
Vesting date of warrants			Apr. 21, 2016
Vesting date of warrants			24 months
Outside Consultant Warrants [Member] \| Tranche Two [Member]
Warrants:
Expiration date of warrants			Apr. 21, 2021
Vesting date of warrants			24 months
Outside Consultant Warrants #2 [Member]
Warrants:
Warrants granted (shares)					245,000
Grant date fair value (in dollars per share)					$ 4.78
Expected term					5 years
Dividend yield					0.00%
Weighted average exercise price of warrants					$ 7.90
Outside Consultant Warrants #2 [Member] \| Tranche One [Member]
Warrants:
Warrants granted (shares)					75,000
Expiration date of warrants					Apr. 21, 2021
Vesting date of warrants					Apr. 21, 2016
Outside Consultant Warrants #2 [Member] \| Tranche Two [Member]
Warrants:
Warrants granted (shares)					50,000
Expiration date of warrants					Apr. 21, 2021
Vesting date of warrants					24 months
Outside Consultant Warrants #2 [Member] \| Tranche Three [Member]
Warrants:
Warrants granted (shares)					120,000
Expiration date of warrants					Jan. 21, 2021
Vesting date of warrants					12 months
Outside Consultant Warrants #3 [Member]
Warrants:
Exercise price of warrants (in dollars per share)				$ 6.35		$ 6.35
Warrants granted (shares)				50,000		50,000
Expiration date of warrants				Apr. 06, 2020
Consultant Agreement - Warrants [Member]
Warrants:
Exercise price of warrants (in dollars per share)	$ 2.01
Warrants granted (shares)	283,333	283,333					850,000
Fair value of grant		$ 462,196
Share based compensation expense			$ 0	$ 38,517	$ 77,026	$ 115,551
Expected term		5 years
Volatility rate		45.84%
Risk free rate		1.41%
Dividend yield		0.00%
Expected to vested warrants upon FDA approval (in shares)			283,334		283,334		283,334
Unamortized noncash compensation associated with warrants			$ 193,347		$ 193,347		$ 193,347
Warrants [Member]
Warrants:
Share based compensation expense			$ 64,449	$ 64,449	$ 193,347	$ 193,347
Weighted average exercise price of warrants					$ 2.08
Stock issued for excercised warrants, shares					722,744	945,485
Stock issued for excercised warrants					$ 1,373,000	$ 366,000
Warrants - Cashless Exercise [Member]
Warrants:
Stock issued for excercised warrants, shares				232,197		232,197
Warrants exercised				310,000		310,000
Total Warrants Exercised [Member]
Warrants:
Warrants exercised						1,255,485
Minimum [Member] \| Outside Consultant Warrants #2 [Member]
Warrants:
Volatility rate					74.10%
Risk free rate					1.04%
Maximum [Member] \| Outside Consultant Warrants #2 [Member]
Warrants:
Volatility rate					74.15%
Risk free rate					1.28%
Warrants [Member] \| Minimum [Member]
Warrants:
Exercise price of warrants (in dollars per share)			$ 0.24		$ 0.24		$ 0.24
Warrants [Member] \| Maximum [Member]
Warrants:
Exercise price of warrants (in dollars per share)			$ 8.20		$ 8.20		$ 8.20